Founded in 1989, OPTEL is now a multinational, leading global provider of traceability systems practicing responsible human capitalism. The company’s mission is to use its innovative technologies to help create a better world.
Namely, its renowned solutions ensure the quality of consumer health products and help stop counterfeiting of pharmaceuticals and medical devices throughout the world. In addition, OPTEL is adapting its technologies to create efficiencies in various other sectors ─ from health-related industries to smart manufacturing and more, all can benefit from global traceability.
Through advanced characterization and cutting-edge algorithms ─ now all connected through the Internet of Things ─ OPTEL’s expert traceability solutions will allow diverse industries to measure, inspect, control and track a wide range of elements to improve product quality and make better use of resources.
Based in Canada with additional facilities in Ireland, India, and Brazil, as well as employees worldwide, OPTEL has expanded significantly in the past few years in order to meet growing industry needs and to support its humanitarian values. OPTEL is also a Certified B Corporation.
OPTEL embarks on a project that is as original as it is beneficial: urban beekeeping. By installing beehives on the roof of their headquarters in the Québec Metro High Tech Park, OPTEL takes concrete action in regard to sustainable development.
OPTEL is proud to be a Certified B Corporation, a group of companies that are leading a movement to use business as a force for good, meeting rigorous standards of social and environmental performance, accountability, and transparence.
OPTEL GROUP, a leading global provider of traceability systems for the pharmaceutical and medical device industries, announced today that it officially inaugurated its new manufacturing facilities in Campinas, Brazil.
This means in turn that our 100th employee, marks a firm 60% increase to the staff numbers this year at the EMEA Operations in Limerick.
The Investissement Québec CEO of the Year 2017 award, presented by the Quebec Technology Association, was granted on Thursday, February 16, 2017. Each year, this award recognizes the technology companies’ presidents who stand out through their leadership. Louis Roy was chosen for the innovative nature of his achievements, his contribution to them as well as the importance of his management when difficulties occur.
OPTEL GROUP CELEBRATES OFFICIAL GRAND OPENING OF ITS NEW FACILITY IN INDIA
Inaugurated yesterday, this 42,000 sq. ft. facility will allow Optel Group’s business units to enhance their presence in Asia. Optel Vision, the most prominent of Optel Group’s business units, specializing in the serialization and traceability of pharmaceutical products, has been present in India since 2012 and is already ranked the top provider in its field there.
All employees and managers of Optel Group and its business units are committed to respecting this environmental policy.
OPTEL GROUP LAUNCHES A NEW BUSINESS UNIT
Quebec City, October 24, 2016 – Optel Group, parent company of Optel Vision and world-leading provider of inspection and traceability systems, announced today that it is launching a new business unit: Optel Medevon.
Optel Group aims to demonstrate the viability of this new business model that can benefit investors, management, employees and society alike. “All entrepreneurs carry within them the desire to give back to society and make the world a better place. Together, we can build a viable future for our children.” – Louis Roy, President Optel Group
At Optel Group, we promote innovation as a way to facilitate access to better living conditions, particularly for the world’s children. We have a duty to ensure a healthy environment for future generations so that all children are born with the opportunity to reach their full potential within their communities.
Since its inception in 1989, Optel has served the pharmaceutical industry, helping ensure product safety through the development of cutting-edge inspection and serialization systems for pharmaceutical production lines. Today, Optel is considered the leading provider of pharmaceutical traceability systems thanks to its large market share and wide customer base, including eight of the top ten generic drug manufacturers in the world.Read More
As part of its mission to create efficiencies in health-related sectors, Optel has recently expanded its offering to include the medical device industry. More specifically, Optel provides customized inspection, verification and tracking solutions that comply with device identification regulatory requirements. Based on nearly 30 years of renowned expertise developing and installing regulation-compliant Track & Trace systems, Optel now bring all the advantages of proven inspection technologies and applies them to medical devices and their packaging.
At Optel Group, we work with customers and employees around the world to help ensure that our technology is used to benefit society.
With over 1000 employees globally, Optel Group operates from locations in Canada, Ireland, India and Brazil. At our corporate headquarters in Quebec City, Canada, more than 750 employees work together to support our worldwide business units, whose main mandate is to develop new markets in which our technology can serve a higher collective purpose.
Our unique engineering process for integrating highly complex solutions, combined with our global reach, allows Optel Group to support major industrial players by leveraging one main partner to solve a number of important issues around the world.
Optel Group Headquarters
2680, boul. du Parc Technologique
Québec (QC) G1P 4S6
Phone: +1 418 688 0334